Global and United States Implantable Drug Delivery Devices Market Insights, Forecast to 2027

SKU ID : QYR-18707824 | Publishing Date : 06-Jul-2021 | No. of pages : 142

Implantable drug delivery devices are an alternative system that can achieve effective delivery with lower drug concentrations, and as a result, minimise side-effects whilst increasing patient compliance.
BD, B.Braun, AngioDynamics, Smiths Medical and Teleflex, etc. are the leading products in the international market, accounting for 85.5% of the global market.

Market Analysis and Insights: Global and United States Implantable Drug Delivery Devices Market
This report focuses on global and United States Implantable Drug Delivery Devices market.
In 2020, the global Implantable Drug Delivery Devices market size was US$ 445.7 million and it is expected to reach US$ 634.9 million by the end of 2027, with a CAGR of 5.2% during 2021-2027. In United States the Implantable Drug Delivery Devices market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Implantable Drug Delivery Devices Scope and Market Size
Implantable Drug Delivery Devices market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Implantable Drug Delivery Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For United States market, this report focuses on the Implantable Drug Delivery Devices market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in United States.

Segment by Type
Titanium Drug Delivery System
Plastic Drug Delivery System
Titanium drug delivery system accounted for the largest proportion, accounting for 65.60% of the market in 2019.

Segment by Application
Intravenous Chemotherapy
Nutrition Support Therapy
Intravenous chemotherapy accounts for the largest proportion, accounting for 80.71% of the market in 2019.

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
BD
B.Braun
AngioDynamics
Smiths Medical
Teleflex
Cook Medical
Fresenius
Vygon
PFM Medical
Districlass
Linhwa

Frequently Asked Questions

This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
  • By product type
  • By End User/Applications
  • By Technology
  • By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
market Reports market Reports